Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00798486 · ClinicalTrials.gov registry record · NA
Evaluation of the A1CNow+ Test Kit
A NA study of Diabetes, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 2
- Study locations
NCT00798486: Completed NA study of Diabetes, sponsored by Ascensia Diabetes Care.
NCT00798486 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 110 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00798486, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.
Primary Outcome
This outcome measure reports the number of A1c test results for which the percent difference (absolute value) between results from the subject meter and the laboratory method was less than or equal to 13.5%.
Conditions Studied
Interventions
- DEVICE A1C Test Kit
Study Locations (2)
California
- John Muir Physician Network Clinical Research Center - Concord
New Jersey
- Consumer Product Testing Co., Inc. - Fairfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00798486 record still lists
NCT00798486 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which A1C Test Kit is the first listed.
NCT00798486 reports a single indexed study location in California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00798486 about?
NCT00798486 is a clinical study titled "Evaluation of the A1CNow+ Test Kit". The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.
What is the current status of trial NCT00798486?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2008-11. Estimated completion is 2008-12.
What conditions does trial NCT00798486 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00798486?
The interventions under investigation include: A1C Test Kit (DEVICE).
Who is sponsoring clinical trial NCT00798486?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00798486 being conducted?
This trial has 2 study locations across California, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00798486's enrollment target sits among peer trials
110 187th of 338 higher than 152 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia